Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

Existing methods of engineering one of the most commonly used gene-delivery vehicles, adeno-associated viruses (AAV), are ...

Aptamer's Optimer technology achieves key milestones in genetic medicine delivery, enhancing targeting specificity and ...

Its lead gene therapy candidate has the potential to be faster, less expensive, and more widely available than current CAR T ...

Oct. 28, 2024 — Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing function. These preclinical ...

AAVs have become the therapeutic gene delivery vehicle of choice because they are non-pathogenic, easy to produce, transduce efficiently across various cell types, and show low immunogenicity.

Watch out, Gilead and Novartis: there's a new CAR-T in town. Autolus is ready to hit the ground ... FELIX study over the peak of the COVID-19 pandemic. Currently, the product delivery team at the ...

The gene's name is derived from Tír na ... They then used a special delivery system—called a polymeric vehicle—to deliver a common antibiotic (doxycycline) directly to the damaged muscle ...

AAVs are widely accepted vehicles to deliver gene therapies ... great confidence to increase our investment in therapeutic gene delivery, to support our neurological disease portfolio,” Roche ...

The gene’s name is derived from Tír na nÓg ... They then used a special delivery system – called a polymeric vehicle – to deliver a common antibiotic (doxycycline) directly to the damaged muscle and ...